Effect of naturally occurring hydroxychavicol acetate on the cytokine production in T helper cells

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 448-454

  Min, Hyun Jung ^a   Nam, Joo Won ^a   Yu, Eun Sun ^a   Hong, Jeong Ho ^b   Seo, Eun Kyoung ^a   Hwang, Eun Sook ^a  

^a Ewha Womans University   (South Korea)

^b Korea University   (South Korea)

Author keywords

Acetoxychavicol acetate; Hydroxychavicol acetate; IFN ; IL 2; T helper cell; T bet

Indexed keywords

ACETOXYCHAVICOL ACETATE; ALPINIA GALANGA EXTRACT; GAMMA INTERFERON; HYDROXYCHAVICOL ACETATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN C FOS; REACTIVE OXYGEN METABOLITE; STAT5 PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ALPINIA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELPER CELL; IMMUNOBLOTTING; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ALPINIA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; APOPTOSIS; BENZYL ALCOHOLS; CELL DIFFERENTIATION; CYTOKINES; INTERFERON-GAMMA; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 61649091283     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.008     Document Type: Article

References (37)

1. Liu Y., Murakami N., Zhang S., and Xu T. Structure-activity relationships of 1′-acetoxychavicol acetate homologues as new nuclear export signal inhibitors. Pharmazie 62 (2007) 659-662
2. Matsuda H., Ando S., Morikawa T., Kataoka S., and Yoshikawa M. Structure-activity relationships of 1′S-1′-acetoxychavicol acetate for inhibitory effect on NO production in lipopolysaccharide-activated mouse peritoneal macrophages. Bioorg Med Chem Lett 15 (2005) 1949-1953
3. Muangnoi P., Lu M., Lee J., Thepouyporn A., Mirzayans R., Le X.C., et al. Cytotoxicity, apoptosis and DNA damage induced by Alpinia galanga rhizome extract. Planta Med 73 (2007) 748-754
4. Sun Y., Tabata K., Matsubara H., Kitanaka S., Suzuki T., and Yasukawa K. New cytotoxic diarylheptanoids from the rhizomes of Alpinia officinarum. Planta Med 74 (2008) 427-431
5. Ye Y., and Li B. 1′S-1′-acetoxychavicol acetate isolated from Alpinia galanga inhibits human immunodeficiency virus type 1 replication by blocking Rev transport. J Gen Virol 87 (2006) 2047-2053
6. Yu J.G. Identification of the chemical components of two Alpinia species. Zhong Yao Tong Bao 13 (1988) 34-36 63
7. Janssen A.M., and Scheffer J.J. Acetoxychavicol acetate, an antifungal component of Alpinia galanga. Planta Med (1985) 507-511
8. Matsuda H., Morikawa T., Managi H., and Yoshikawa M. Antiallergic principles from Alpinia galanga: structural requirements of phenylpropanoids for inhibition of degranulation and release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem Lett 13 (2003) 3197-3202
9. Ly T.N., Shimoyamada M., Kato K., and Yamauchi R. Isolation and characterization of some antioxidative compounds from the rhizomes of smaller galanga (Alpinia officinarum Hance). J Agric Food Chem 51 (2003) 4924-4929
10. Ly T.N., Shimoyamada M., Kato K., and Yamauchi R. Antioxidative compounds isolated from the rhizomes of smaller galanga (Alpinia officinarum Hance). Biofactors 21 (2004) 305-308
11. Morikawa T., Ando S., Matsuda H., Kataoka S., Muraoka O., and Yoshikawa M. Inhibitors of nitric oxide production from the rhizomes of Alpinia galanga: structures of new 8-9′ linked neolignans and sesquineolignan. Chem Pharm Bull (Tokyo) 53 (2005) 625-630
12. Murakami A., Toyota K., Ohura S., Koshimizu K., and Ohigashi H. Structure-activity relationships of (1′S)-1′-acetoxychavicol acetate, a major constituent of a southeast Asian condiment plant Languas galanga, on the inhibition of tumor-promoter-induced Epstein-Barr virus activation. J Agric Food Chem 48 (2000) 1518-1523
13. Lee C.C., and Houghton P. Cytotoxicity of plants from Malaysia and Thailand used traditionally to treat cancer. J Ethnopharmacol 100 (2005) 237-243
14. Ito K., Nakazato T., Murakami A., Yamato K., Miyakawa Y., Yamada T., et al. Induction of apoptosis in human myeloid leukemic cells by 1′-acetoxychavicol acetate through a mitochondrial- and Fas-mediated dual mechanism. Clin Cancer Res 10 (2004) 2120-2130
15. Watanabe N., Kataoka T., Tajika T., Uramoto M., Magae J., and Nagai K. 1′-Acetoxychavicol acetate as an inhibitor of phagocytosis of macrophages. Biosci Biotechnol Biochem 59 (1995) 1566-1567
16. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
17. Glimcher L.H. Lineage commitment in lymphocytes: controlling the immune response. J Clin Invest 108 (2001) s25-s30
18. Rengarajan J., Szabo S.J., and Glimcher L.H. Transcriptional regulation of Th1/Th2 polarization. Immunol Today 21 (2000) 479-483
19. Van Parijs L., Refaeli Y., Lord J.D., Nelson B.H., Abbas A.K., and Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11 (1999) 281-288
20. Zamorano J., Wang H.Y., Wang R., Shi Y., Longmore G.D., and Keegan A.D. Regulation of cell growth by IL-2: role of STAT5 in protection from apoptosis but not in cell cycle progression. J Immunol 160 (1998) 3502-3512
21. Lin J.X., and Leonard W.J. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19 (2000) 2566-2576
22. Bopp T., Palmetshofer A., Serfling E., Heib V., Schmitt S., Richter C., et al. NFATc2 and NFATc3 transcription factors play a crucial role in suppression of CD4+ T lymphocytes by CD4+ CD25+ regulatory T cells. J Exp Med 201 (2005) 181-187
23. Kontgen F., Grumont R.J., Strasser A., Metcalf D., Li R., Tarlinton D., et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9 (1995) 1965-1977
24. Novak T.J., White P.M., and Rothenberg E.V. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res 18 (1990) 4523-4533
25. Peng S.L., Gerth A.J., Ranger A.M., and Glimcher L.H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14 (2001) 13-20
26. Powell J.D., Ragheb J.A., Kitagawa-Sakakida S., and Schwartz R.H. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 165 (1998) 287-300
27. Serfling E., Avots A., and Neumann M. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim Biophys Acta 1263 (1995) 181-200
28. Hwang E.S., Hong J.H., and Glimcher L.H. IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508. J Exp Med 202 (2005) 1289-1300
29. Nam J., Kim S., Han A., Lee S., and Seo E. Cytotoxic phenylpropanoids from the rhizomes of Alpinia galanga. J Appl Pharmacol 13 (2005) 263-266
30. Nakamura Y., Murakami A., Ohto Y., Torikai K., Tanaka T., and Ohigashi H. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′-acetoxychavicol acetate. Cancer Res 58 (1998) 4832-4839
31. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
32. Szabo S.J., Sullivan B.M., Stemmann C., Satoskar A.R., Sleckman B.P., and Glimcher L.H. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295 (2002) 338-342
33. Moffatt J., Hashimoto M., Kojima A., Kennedy D.O., Murakami A., Koshimizu K., et al. Apoptosis induced by 1′-acetoxychavicol acetate in Ehrlich ascites tumor cells is associated with modulation of polyamine metabolism and caspase-3 activation. Carcinogenesis 21 (2000) 2151-2157
34. Ito K., Nakazato T., Murakami A., Ohigashi H., Ikeda Y., and Kizaki M. 1′-Acetoxychavicol acetate induces apoptosis of myeloma cells via induction of TRAIL. Biochem Biophys Res Commun 338 (2005) 1702-1710
35. Campbell C.T., Prince M., Landry G.M., Kha V., and Kleiner H.E. Pro-apoptotic effects of 1′-acetoxychavicol acetate in human breast carcinoma cells. Toxicol Lett 173 (2007) 151-160
36. Mori A., Suko M., Kaminuma O., Inoue S., Ohmura T., Hoshino A., et al. IL-2-induced IL-5 synthesis, but not proliferation, of human CD4+ T cells is suppressed by FK506. J Immunol 158 (1997) 3659-3665
37. Zhou W., Zhang F., and Aune T.M. Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells. J Immunol 170 (2003) 735-740